In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human. This was the first successful transplant of a genetically modified pig’s heart into a human patient.

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of February. This data was drawn from dicardiology.com’s 149,000 viewers over the course of the month.

March 4, 2022 – NewAmsterdam Pharma (NAP), a clinical-stage company focused on the research and development of transformative therapies for cardiometabolic diseases, today announced dose administration for the first patient in its PREVAIL study, a global Phase 3 cardiovascular outcomes trial of the novel cholesteryl ester transfer protein (CETP) inhibitor obicetrapib.

March 3, 2022 – CIRCA Scientific, Inc. has announced that its S-CATH M Esophageal Temperature Probe is now cleared for sale in the United States. The new S-CATH M Probe can be visualized on 3D Cardiac Mapping Systems, which may help physicians reduce their dependence on fluoroscopy.

March 3, 2022 – Spontaneous coronary artery dissection (SCAD), a tear in an artery supplying blood to the heart, is a common cause of serious or fatal heart attacks that occur in women under age 50.

March 3, 2022 – The University of Maryland School of Medicine’s Institute of Human Virology, a Global Virus Network (GVN) Center of Excellence, physician researchers played a collaborative role in last month’s successful transplant of a genetically-modified pig heart into a patient with terminal heart disease by creating pathogen surveillance strategies and developing an infection prevention strategy for this unprecedent significant medical advancement.

March 2, 2022 – As 1-year-old SaRyia Moore and her family celebrate American Heart Month, they do so will full, grateful hearts — including SaRyia's transplanted heart she received just eight weeks ago, saving her young life.

March 2, 2022  – HeartFlow, Inc. has announced that John Farquhar has been appointed President and Chief Executive Officer, effective March 1, 2022.  Farquhar has served as HeartFlow’s President and a member of the board since January 1, 2022. John H. Stevens, M.D. will continue to serve on the Board of Directors as Vice Chair.

March 2, 2022 – An international study led by a researcher from Tel Aviv University offers a novel technology that can assist many patients implanted with bioprosthetic heart valve by avoiding additional complicated replacement surgery. Many heart patients implanted with such valves are forced to replace it ten years later due to calcification of valve tissue.

 

March 1, 2022 – To meet the growing industry demand for highly trained clinical professionals specializing in cardiac rhythm management and electrophysiology, Harding University has created the first Master of Science in Cardiac Function and Interventional Technology (CFIT) degree program in the nation.

March 1, 2022 – The larger the sail, the more wind it catches. But as that size increases, so does the stress experienced by each sheet and line connected to the canvas.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now